CVE-2015-1011

CVE-2015-1011 is a medium-severity vulnerability in Hospira Lifecare Pcainfusion Firmware with a CVSS 2.0 base score of 5.0. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-200.

Key facts

Description

Hospira LifeCare PCA Infusion System before 7.0 has hardcoded credentials, which makes it easier for remote attackers to obtain access via unspecified vectors.

Frequently asked questions

What is CVE-2015-1011?
Hospira LifeCare PCA Infusion System before 7.0 has hardcoded credentials, which makes it easier for remote attackers to obtain access via unspecified vectors.
How severe is CVE-2015-1011?
CVE-2015-1011 has a CVSS 2.0 base score of 5.0, rated medium severity.
Is CVE-2015-1011 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (81st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2015-1011?
CVE-2015-1011 affects Hospira Lifecare Pcainfusion Firmware. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2015-1011?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2015-1011 published?
CVE-2015-1011 was published on 2015-07-06 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Hospira Lifecare Pcainfusion Firmware

All CVEs affecting Hospira Lifecare Pcainfusion Firmware →

Other CWE-200 (Exposure of Sensitive Information to an Unauthorized Actor) vulnerabilities

Browse all CWE-200 (Exposure of Sensitive Information to an Unauthorized Actor) vulnerabilities →